131 related articles for article (PubMed ID: 3880372)
1. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
[No Abstract] [Full Text] [Related]
2. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
[TBL] [Abstract][Full Text] [Related]
3. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
Roztocil K; Oliva I; Prerovský I; Linhart J
Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
[TBL] [Abstract][Full Text] [Related]
4. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
Matagne D; Hamoir G
Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
[No Abstract] [Full Text] [Related]
5. [Venoruton--used not only in venopathies? Symposium on O-(beta-hydroxyethyl)-rutoside (=Venoruton) in vascular diseases].
ZFA (Stuttgart); 1981 Sep; 57(26):1758-60. PubMed ID: 7303836
[No Abstract] [Full Text] [Related]
6. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
[No Abstract] [Full Text] [Related]
7. New pharmacological and clinical properties of the venoactive agent: Venoruton (Paroven). Studies presented at the 1st Mediterranean Congress of Angiology. Corfu, Greece, May 29 to June 3, 1988. Abstracts.
Int Angiol; 1988; 7(4 Suppl):1-16. PubMed ID: 3249081
[No Abstract] [Full Text] [Related]
8. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
van Haeringen NJ
Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
[No Abstract] [Full Text] [Related]
9. Anticatatonic effect of venoruton.
Aley KO; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):263-5. PubMed ID: 2898576
[TBL] [Abstract][Full Text] [Related]
10. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Pedersen FM; Hamberg O; Sørensen MD; Neland K
Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
[TBL] [Abstract][Full Text] [Related]
11. [Do troxerutin and sodium rutin sulfate still possess the properties of rutin?].
Brasseur T; Angenot L; Pincemail J; Deby C
Ann Pharm Fr; 1987; 45(4):329-34. PubMed ID: 3445996
[No Abstract] [Full Text] [Related]
12. O-(beta-hydroxyethyl)-rutoside (Venoruton) fails to block histamine or bradykinin-induced edema formation in the canine forelimb perfused at constant arterial inflow.
Dobbins DE; Soika CY; Dabney JM
Microcirc Endothelium Lymphatics; 1984 Oct; 1(5):509-23. PubMed ID: 6546155
[TBL] [Abstract][Full Text] [Related]
13. Effect of venoruton on hypoxic stress-induced neurotoxicity in mice and oxygen free radical generation by human neutrophils.
Shukla VK; Sethi AK; Garg SK; Ganguly NK; Kulkarni SK
Arch Int Pharmacodyn Ther; 1989; 299():127-33. PubMed ID: 2774763
[TBL] [Abstract][Full Text] [Related]
14. Effect of Venoruton on the factor XIII activity in rat plasma.
Grochal M; Sempińska-Edelberg E; Plewiński J
Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
[TBL] [Abstract][Full Text] [Related]
15. Effect of o-(beta-hydroxyethyl)-rutoside in lymphangiography.
Broks PD
AJR Am J Roentgenol; 1977 Feb; 128(2):263-5. PubMed ID: 401613
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of cystoid macular edema with O-beta-hydroxyethyl-rutoside (Venoruton) in a double-blind study].
Artaria LG
Klin Monbl Augenheilkd; 1982 Jun; 180(6):568-70. PubMed ID: 6752553
[No Abstract] [Full Text] [Related]
17. The effect of O-(beta-hydroxyethyl)-rutoside (HR) on macromolecular leakage, thrombosis and haemostasis in experimental animals.
Bergqvist D; Svensjö E; Arfors KE
Ups J Med Sci; 1978; 83(2):123-7. PubMed ID: 664118
[TBL] [Abstract][Full Text] [Related]
18. No effect of O-(beta-hydroxyethyl)-rutoside on red cell filterability in patients with acute myocardial infarction.
Waldenlind L; Edlund BL; Hulting J; Lund F
J Intern Med; 1990 Dec; 228(6):655-6. PubMed ID: 2280245
[No Abstract] [Full Text] [Related]
19. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography.
Forconi S; Guerrini M; Di Perri T
Vasa; 1977; 6(3):279-84. PubMed ID: 335696
[No Abstract] [Full Text] [Related]
20. o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
Bull JM; Strebel FR; Sunderland BA; Bulger RE; Edwards M; Siddik ZH; Newman RA
Cancer Res; 1988 Apr; 48(8):2239-44. PubMed ID: 3349489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
